Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study

Efficacy, Safety and Pharmacoeconomic Analysis of Intravenous Ferric Carboxymaltose in Anemic Hemodialysis Patients Unresponsive to Ferric Gluconate Treatment: A Multicenter Retrospective Study

Patients undergoing hemodialysis with iron deficiency anemia (IDA) receiving treatment with erythropoiesis-stimulating agents (ESAs) who were intolerant or non-responsive to intravenous (i.v.) ferric gluconate (FG) (hemoglobin; Hb values < 10.5 g/dL or increase in <1 g/dL) or % transferrin sat...

Full description

Bibliographic Details
Main Authors: Alberto Rosati, Paolo Conti, Patrizia Berto, Sabrina Molinaro, Federica Baldini, Colin Gerard Egan, Vincenzo Panichi
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Clinical Medicine
Subjects:
ferric carboxymaltose
intravenous iron supplementation
iron deficiency anemia
chronic kidney disease
hemodialysis
hemoglobin
Online Access:https://www.mdpi.com/2077-0383/11/18/5284

Internet

https://www.mdpi.com/2077-0383/11/18/5284

Similar Items